Publicaciones científicas

Búsqueda avanzada

Mieloma múltiple y nuevos fármacos

Año: 2012
- Multiple myeloma: treatment evolution
  San Miguel JF; Mateos MV; Ocio E; Garcia-Sanz R.
  Hematology 17: 3-6. FI: 1,487 (Q3) (D8)
  PubMed
- Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?
  Matarraz S; Paiva B; Diez-Campelo M; Corral LL; Pérez E; Mateos MV; Giraldo P; Hernández MT; San Miguel JF; Orfao A
  Haematologica-The Hematology Journal. 97: 1608-1611. FI: 6,424 (Q1) (D1)
  PubMed
- MyelomA Genetics International Consortium.
  Morgan G; Johnsen HE; Goldschmidt H; Palumbo A; Cavo M; Sonneveld P; Miguel JS; Chim CS; Browne P; Einsele H; Waage A; Turesson I; Spencer A; Hajek R; Ludwig H; Hemminki K; Houlston R.
  Leukemia & Lymphoma 53: 796-800. FI: 2,580 (Q2) (D5)
  PubMed
- Novel agents derived from the currently approved treatments for MM: novel proteasome inhibitors and novel IMIDs
  Ocio EM; Mateos MV; San-Miguel JF.
  Expert Opinion On Investigational Drugs 21: 1075-1087. FI: 5,274 (Q1) (D1)
  PubMed
- Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment
  Chanan-Khan AA; San Miguel JF; Jagannath S; Ludwig H; Dimopoulos MA
  Clinical Cancer Research 18: 2145-2163. FI: 7,742 (Q1) (D1)
  PubMed
- Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use
  Muntion, S.; Sanchez-Guijo, F. M.; Carrancio, S.; Villaron, E.; Lopez, O.; Diez-Campelo, M.; San Miguel, J. F.; del Canizo, M. C
  Muntion, S.; Sanchez-Guijo, F. M.; Carrancio, S.; Villaron, E.; Lopez, O.; Diez-Campelo, M.; San Miguel, J. F.; del Canizo, M. C 22: 122-127. FI: 1,140 (Q4) (D10)
  PubMed
- Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia.
  Lapusan S; Vidriales MB; Thomas X; de Botton S; Vekhoff A; Tang R; Dumontet C; Morariu-Zamfir R; Lambert JM; Ozoux ML; Poncelet P; San Miguel JF; Legrand O; DeAngelo DJ; Giles FJ; Marie JP
  Investigational New Drugs. 30: 1121-1131. FI: 3,357 (Q1) (D3)
  PubMed
- Proteasome inhibitors in multiple myeloma: 10 years later.
  Moreau P; Richardson PG; Cavo M; Orlowski RZ; San Miguel JF; Palumbo A; Harousseau JL
  Blood 120: 947-959. FI: 9,898 (Q1) (D1)
  PubMed
- Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival
  Santamaría C; Ramos F; Puig N; Barragán E; de Paz R; Pedro C; Insunza A; Tormo M; Del Cañizo C; Diez-Campelo M; Xicoy B; Salido E; Del Real JS; Hernández M; Chillón C; Sanz GF; García-Sanz R; San Miguel JF; González M.
  Annals Of Hematology Annals Of Hematology
  PubMed
- SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status
  .. López-Corral L; Sarasquete ME; Beà S; García-Sanz R; Mateos MV; Corchete LA; Sayagués JM; García EM; Bladé J; Oriol A; Hernández-García MT; Giraldo P; Hernández J; González M; Hernández-Rivas JM; San Miguel JF; Gutiérrez NC
  Leukemia 26: 2521-2529. FI: 9,561 (Q1) (D1)
  PubMed

204 resultados

Páginas: < 1 2 3 4 5 > >>

NoticiasNoticias
Zona del InvestigadorZona del Investigador